Proteintech Group

Chicago, United States Founded: 2002 • Age: 24 yrs Acquired By 10X Genomics
Supplies high-quality antibodies, immunoassays, and cytokines for scientific applications globally.

About Proteintech Group

Proteintech Group is a Healthcare company based in Chicago (United States) founded in 2002, and was acquired by 10X Genomics in June 2026. It supplies high-quality antibodies, immunoassays, and cytokines for scientific applications globally. It operates on a B2B and Direct Sales model. Proteintech Group has completed 1 acquisition, including Chromo Tek. Proteintech Group offers products and services including Antibodies, ELISA Kits, and Cytokines and Growth Factors. Its focus areas include Biotechnology, Life Sciences Tools, Antibody Production and Research Reagents. Its legal entity is Proteintech Group, Inc. Its competitors include GenScript, Vector Laboratories and Epitomics; 2 of its 3 listed competitors have raised funding.

Company details

Proteintech Group develops and distributes antibodies, recombinant proteins, ELISA kits, and immunoassay tools for research in fields like Western Blot and Flow Cytometry. They operate through online sales and custom services, serving global researchers and institutions. Headquartered in Rosemont, IL, USA, they emphasize quality products for applications in cancer, immunology, and more, with facilities in Europe for broader reach.

  • Headquarters Chicago, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ptglab.com
  • Social LinkedIn
  • Acquired by 10X Genomics (Jun 2026)
  • Legal Name Proteintech Group, Inc.
Key Metrics

Products & Services of Proteintech Group

Proteintech Group offers a comprehensive portfolio of products and services, including Antibodies, ELISA Kits, and Cytokines and Growth Factors.

Antibodies
Research Reagents

Primary and secondary antibodies for applications like Western Blot and IHC.

ELISA Kits
Immunoassays

Kits for detecting proteins in research and diagnostics.

Cytokines and Growth Factors
Biochemical Products

Recombinant proteins for cell culture and signaling studies.

Investors in Proteintech Group

Proteintech Group has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.

All
InvestorDescriptionFounded YearDomainLocation
Instrument systems for genomic research and sequencing libraries are developed.
201210xgenomics.comPleasanton, United States
Premium access

Investor details for Proteintech Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Proteintech Group

2 people are tracked at Proteintech Group (2 in leadership).

NameRoleGroup
Kristopher Nazor
Chief Executive OfficerLeadership
Nicholas Scheidler
Vice President, OperationsLeadership
Premium access

Complete people profiles for Proteintech Group

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Proteintech Group

Proteintech Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chromo Tek.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Immunologic research tools for cell biology and proteomics are provided.
chromotek.comPlanegg, Germany2008Oct 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Proteintech Group

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Proteintech Group

3 dated milestones of Proteintech Group across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Proteintech Group is founded.
  2. Acquisition Acquires Chromo Tek.
  3. Exit Acquired by 10X Genomics.

Competitors of Proteintech Group

Proteintech Group has 3 listed competitors in our database, 2 of them funded. They include GenScript, Vector Laboratories and Epitomics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
vectorlabs.com1976Burlingame, United States
Labeling and detection reagents immunohistochemistry studies and other life science research applications
epitomics.com2001Burlingame, United States$16.21M
Monoclonal antibody technology and products are developed by Epitomics.
Premium access

Detailed competitors of Proteintech Group

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Proteintech Group

Websites that share an audience with Proteintech Group (ptglab.com).

Similar websites

Websites whose visitors overlap most with Proteintech Group. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
hispanagar.com
100%
3.5K#5,063,712View details
fusionantibodies.com
100%
View details
haemtech.com
100%
View details
abgent.com
99%
View details
abnova.com
97%
30.7K#957,320View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Proteintech Group

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as Proteintech Group (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Proteintech Group

CEMEX’s Acquisition of Majority Stake in ProSteinGroup
Globallegalchronicle β€’ 4 years ago
Bellot leads sales drive at biotech firm Cellexus
Dailybusinessgroup β€’ 4 years ago
Premium access

Complete news archive for Proteintech Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Proteintech Group

Proteintech Group was founded in 2002.

Proteintech Group is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Proteintech Group develops and distributes antibodies, recombinant proteins, ELISA kits, and immunoassay tools for research in fields like Western Blot and Flow Cytometry. They operate through online sales and custom services, serving global researchers and institutions. Headquartered in Rosemont, IL, USA, they emphasize quality products for applications in cancer, immunology, and more, with facilities in Europe for broader reach.

Proteintech Group's top competitors include GenScript, Epitomics and Vector Laboratories.

Proteintech Group offers Antibodies, ELISA Kits, and Cytokines and Growth Factors.

Proteintech Group has made 1 acquisition, including Chromo Tek.

Proteintech Group has 1 investor. Key investors include 10X Genomics.

Proteintech Group operates through Proteintech Group, Inc..

Yes. Proteintech Group was acquired by 10X Genomics in June 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available